semaglutide and smoking Could Ozempic curb your cigarettes craving? A new study suggests may help people quit Novo Nordisk's Ozempic Could Help

When acetate still makes sense The acetate form of BPC-157 is not obsolete

The ultimate tragedy is not the oppression and cruelty by the bad people but the silence over that by the good people

Obesity and adipose tissue research Type 2 diabetes and insulin resistance Knee osteoarthritis Obstructive sleep apnea Non-alcoholic steatohepatitis (NASH) Key Findings from the Literature 01Phase 2: 24.2% mean weight loss at 48 weeks at highest dose 02Phase 3 TRIUMPH-4: 28.7% mean weight loss at 68 weeks 03Highest weight loss efficacy of any obesity pharmacotherapy in clinical trials to date 04Glucagon receptor agonism adds hepatic lipolysis absent from GLP-1-only agents 1 Independent third-party lab reports for this peptide

In TRANSCEND-T2D-1 (type 2 diabetes): nausea 26.5%, diarrhea 22.8%, vomiting 17.6%, dysesthesia 4.4%